European funds investing delights as markets end August higher (LON:FEV)

Fidelity

Fidelity European Trust PLC (LON:FEV) monthly factsheet for August 2024.

Portfolio Manager Commentary 

The month started with big negative equity market moves prompted by the Bank of Japan’s decision to increase interest rates by 25 basis points in early August, and subsequent unwind of ‘carry trades’ that had relied on cheap Japanese debt to fund investments in global risk assets. Market sentiment was also impacted by weak US economic data. Specifically, a small increase in the unemployment rate sparked fears of a US recession. However, Continental European equities, along with other equity markets, recovered through the month and ended higher in August but underperformed the US market. 

The Trust marginally underperformed the index in August. The underperformance was driven by weak stock picking in the healthcare and consumer discretionary sectors with gearing also contributing modestly to the underperformance. The Trust’s holdings in ASML and Puma were the top two detractors. ASML’s shares were impacted by the overall weakness in the semiconductor sector after the US chipmaker Intel reported disappointing earnings and announced a cost-cutting plan to reduce jobs and suspend dividend payments. The Trust’s holding in PUMA was weak after the company reported lacklustre Q2’24 results. However, the Trust’s exposure to Deutsche Börse added value after the company announced settlements with some plaintiffs related to Postbank acquisition lawsuits. Elsewhere, luxury conglomerate Hermès and low-cost airline Ryanair were also modest contributors.   

On a rolling 12-month basis, the Trust recorded NAV and share price returns of 17.1% and 14.8% respectively, compared to 15.8% for the index.  

Share on:
Find more news, interviews, share price & company profile here for:

Capture growth investment opportunities in Europe in 2026

Portfolio managers Sam Morse and Marcel Stötzel outline why they continue to see opportunity in Europe in 2026.

European Investment Trust performance boosted by Roche drug trial success (LON: FEV)

Continental European markets delivered positive returns in November. Fidelity European Trust saw encouraging contributions from Roche and ABN AMRO and remains positioned for long-term growth through disciplined stock selection and a focus on sustainable cash flows.

Fidelity European Trust rose in October with chipmaker ASML top contributor

Fidelity European Trust reported several positives in October, with strong contributions from ASML and Assa Abloy following solid Q3 updates and resilient demand in key areas.

Are European equities set for a revival?

Marcel Stötzel, Co-Portfolio Manager of Fidelity European Trust, remains positive on Europe’s investment outlook, citing structural reforms, rising defence spending and potential economic integration as key drivers.

Fidelity European Trust continued rise as shares advanced in ASML and AIB

Fidelity European Trust has published its September 2025 factsheet, noting European equities finished the quarter higher despite mixed sector performance.

Investing in Europe: Why investors should remain positive

Co-Portfolio Manager of the Fidelity European Trust PLC (LON:FEV), outlines why he believes quality businesses backed by strong balance sheets and dividend growth potential remain well placed to deliver strong relative returns over the long-term.

Search

Search